Listen

Description

Hunter Hastings
Hunter Hastings is an economist who took up a career in corporate marketing and occupied the posts of Chief Marketing Officer in a global consumer products business, Chief Executive Officer in a Silicon Valley start-up enterprise, and Senior Partner in a global consulting company. He’s been an advisor to several Fortune 500 clients in the area of customer motivation and service strategy. Hastings has been an adjunct professor at Hult International Business School, the largest global graduate business school, and is the author / co-author of seven books spanning business and economics, and several peer-reviewed economics papers.

Eric Abecassis
Eric Abecassis is a passionate technologist, entrepreneur, and endurance sports enthusiast with interests in science, literature, and art. He earned a PhD in Computer Science in the early '90s, contributing to database and software architecture research. Eric's career progressed from technical roles to leadership positions, including Chief Architect, Managing Director for Europe, and President of Software at Schlumberger, where he later became CIO. He drove transformative change, championing Agile culture and cutting-edge AI solutions.

Kathy Lee-Sepsick
Kathy Lee-Sepsick founded Femasys in February 2004. Ms. Lee-Sepsick has served as a senior executive in the medical technologies industry for nearly three decades, compiling a successful track record in growing emerging companies and corporate operating divisions. She holds over 100 patents globally for Femasys’ products and product candidates. Ms. Lee-Sepsick was instrumental in the various stages of product and company life cycles with strategic, operational, and executive responsibilities, at start-ups Novoste Corporation, developer of intravascular therapy solution and SaluMedica, biomaterial developer of artificial cartilage. She founded Femasys with a mission to create impactful solutions for women’s health, inspired by her desire to make a difference for her daughters. One of Femasys' groundbreaking biomedical products is designed to perform insemination directly in the fallopian tube called Femaseed.